Nerve-guided surgery for enlarged spleen and bleeding risk
Part of Blood & lymphatic, Digestive system clinical trials.
This study tests a special surgery using a nerve-guided technique to remove the enlarged spleen and reduce bleeding risk in people with cirrhosis and portal hypertension. It may help if you have an enlarged spleen and have had bleeding related to liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of cirrhosis (scarring of the liver).
- You have an enlarged spleen that is causing low blood counts (splenomegaly with hypersplenism).
- You've had bleeding in the esophagus or stomach from high blood pressure in the liver (portal hypertension).
- No blood clot is found in the main vein of your liver (portal vein).
- You must not have severe liver disease (Child-Pugh C), recent ulcers, uncontrolled blood pressure, HIV, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether removing an enlarged spleen (splenectomy) in people with cirrhosis can improve their blood fat (lipid) levels over two years. It may help those with low blood counts due to an overactive spleen.
This study tests whether removing an enlarged spleen through keyhole surgery can improve kidney function in people with cirrhosis and an overactive spleen. The trial follows patients for two years to see if the surgery helps protect the kidneys.
This study tests whether removing part of the liver along with the spleen during laparoscopic (keyhole) surgery helps improve liver function and the immune system in people with liver cancer and cirrhosis. If you qualify, you may have better surgical outcomes and recovery.
This trial tests if apixaban, a blood thinner, is more effective than aspirin at treating blood clots in the portal vein that form more than a year after laparoscopic spleen removal in people with cirrhosis and an enlarged spleen.
This study tests a new procedure that uses an ultrasound-guided scope to shrink part of the spleen (called partial splenic embolization). This may help improve your low platelet count and reduce the risk of future bleeding, especially when other treatments have not been tried.
This trial tests a procedure called splenic artery embolization (blocking part of the blood supply to the spleen) to reduce belly fluid buildup in people with advanced liver disease. It may help if your ascites has not improved with standard treatments and you are not a candidate for TIPS.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.